Abstract
Aliphatic 4-membered (hetero)cycles, such as cyclobutanes and azetidines, are becoming more prevalent as structural features on pharmaceutical leads and drugs. In particular, their rigidity and favorable physicochemical properties allow them to serve as bioisosteric replacements for common drug motifs. Substitution of (hetero)cyclobutanes in stereocontrolled fashion with pharmaceutically relevant functionality is still a modern challenge. Described herein is a method for constructing quaternary (hetero)cyclobutanes and linking them to other (hetero)cycles via an allylic alkylation/exocyclic strain-release Cope rearrangement. The one- or two- step sequence can yield uniquely linked heterocycles bearing an alkylidenemalononitrile functional group, which can be readily transformed into amides diastereoselectively. This study includes optimization and scope studies of the allyic alkylation/[3,3] sequence, enantioselective optimization using asymmetric allylic alkylation, and functional group interconversion studies to yield densely substituted drug-like scaffolds.
Supplementary materials
Title
Supporting Information
Description
Experimental procedures, characterization data (1H NMR, 19F NMR, 13C NMR, HRMS), and computational data.
Actions
Supplementary weblinks
Title
Research Group Website
Description
Please visit our website to learn more about the team and our research!
Actions
View 


![Author ORCID: We display the ORCID iD icon alongside authors names on our website to acknowledge that the ORCiD has been authenticated when entered by the user. To view the users ORCiD record click the icon. [opens in a new tab]](https://www.cambridge.org/engage/assets/public/coe/logo/orcid.png)